International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Razvoj poslovanja
Mediji
Upoznajte nas
Zapošljavanje
Kontaktirajte nas
Proizvodi
Lijekovi
Bezreceptni proizvodi
Partneri i robne marke
PREPORUKA
O nama
Vizija/Misija
Naše vrijednosti
Naša strategija
Rukovodstvo
Korporativna odgovornost
Područje
Razvoj poslovanja
Mediji
Upoznajte nas
Zapošljavanje
Kontaktirajte nas
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Mediji
OBJAVE ZA MEDIJE
1
2
3
4
Sljedeći
15.04.2026
Sugemalimab Receives I, A Recommendation in ESMO Guideline for Consolidation Therapy in Patients with Stage Ⅲ NSCLC
Pročitajte više
26.02.2026
BioGaia AB extends long-standing distribution partnership with Ewopharma
Pročitajte više
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Pročitajte više
31.07.2024
European Commission Approves Sugemalimab
Pročitajte više
03.06.2024
AllergyCare AG staje się częścią Ewopharma Group
Pročitajte više
1
2
3
4
Sljedeći
![[Translate to Croatia:]](/fileadmin/user_upload/Ewopharma_CStone_Sugemalimab_01.png "[Translate to Croatia:]")
